HPV-DNA hybridisation allows discrimination of cervical lesions classified as PAP III;Die HPV-DNA-Hybridisierung ermoglicht eine Differenzierung zervikaler Lasionen bei PAP III Zytobefunden

Geburtshilfe und Frauenheilkunde

Volumn 56, Issue 10, 1996, Pages 509-512

  Petry, K U ^a   Bohmen G ^a   Linge, G ^a   Glaubitz, M ^a   Maschek, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; DIAGNOSTIC AGENT;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; PAPANICOLAOU TEST; PAPILLOMA VIRUS; UTERINE CERVIX CANCER; VIRUS DETECTION; ADULT; CANCER STAGING; CARCINOMA IN SITU; DNA PROBE; GENETICS; IN SITU HYBRIDIZATION; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIRUS INFECTION;

ADULT; CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0029806269     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023274     Document Type: Article

References (18)

1. Burger, M. P. M., H. Hollema, W. J. L.M. Pieters, W. G. V. Quint: Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities. BMJ 310 (1995) 94-95.
2. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah: Prevalence of human papillomavirus in cervical cancer: a world-wide perspective. J. Natl. Cancer. Int. 87 (1995) 796-802.
3. Cox, J. T., M. H. Schiffman, A. J. Winzelberg, J. M. Patterson: An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet. Gynecol. 80 (1992) 389-395.
4. Cox, J. T., A. t. Lörincz, M. H. Schiffman: HPV testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of ASCUS. Am. J. Obstet. Gynecol. 172 (1995) 946-954.
5. Cox, J. T.: HPV DNA testing: clinical boon or boondoggle? Lancet 346 (1995) 717-718.
6. Cuzick, J., A. Szarewski, G. Terry, L. Ho, A. Hanby, P. Maddox, M. Anderson, G. Kocjan, S. T. Steele, J. Guillebaud: Human papillomavirus testing in primary cervical screening. Lancet 345 (1995) 1533-1536.
7. Hatch, K. D., A. Schneider, M. W. Abdel-Nour: An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am. J. Obstet. Gynecol. 172 (1995) 1150-1157.
8. Hurlin, P. J., P. Kaur, P. Smith, N. Perez-Reyes, R. A. Blanton, J. K. McDogall: Progression of human papillomavirus type 18 immortalized keratinocytes to a malignant phenotype. Proc. Natl. Acad. Sci. USA 88 (1991) 570-574.
9. Kesic, V. I., W. P. Soutter, V. Sulovic, N. Juznic, M. Aleksic, A. Ljubic: A comparison of cytology and cervicography in cervical screening. Int. J. Gynecol. Cancer 3 (1993) 395-398.
10. Koss, L. G.: Cervical (Pap) smear. New Directions. Cancer 71 (1993) 1406-1412.
11. Macgregor, J. E., M. K. Campbell, E. M. F. Mann, K. Y., Swanson: Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 308 (1994) 1407-1411.
12. Meijer, C. J. L. M., A. J. C. van der Brule, P. J. F. Snijders, T. Helmerhorst, P. Kenemans, J. M. M. Walboomers: Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. In Munoz, N., F. X. Bosch, K. V. Shah, A. Meheus (Hrsg.): The Epidemiology Of Human Papillomavirus And Cervical Cancer. IARC Scientific Pub. No. 119. Lyon (1992).
13. Raffle, A. E., B. Alden, E. F. D. Mackenzie: Detection rates for abnormal cervical smears: what are we screening for? Lancet 345 (1995) 1469-1473.
14. Petry, K. U., D. Scheffel, U. Bode, T. Gabrysiak, H. Köchel, E. Kupsch, M. Glaubitz, S. Niesert, H. Kühnle, I. Schedel: Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int. J. Cancer 57 (1994) 836-840.
15. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Shermann, S. Wacholder, C. K. Stantaon, M. M. Manos: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85 (1993) 958-964.
16. van den Brule, A. J. C., J. M. M. Walboomers, M. Du Maine, P. Kenemans, C. J. L. M. Meijer: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int. J. Cancer 48 (1991) 404-408.
17. von Knebel-Doeberitz, M., C. Rittmüller, H. zur Hausen, M. Dürst: Inhibition of tumorigenicity of C4-1 cervical cancer cells in nude mice by HPV 18 E6-E7 antisense RNA. Int. J. Cancer 51 (1992) 831-834.
18. Wheelock, J. B., P. F. Kaminski: Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial neoplasia on Papanicolaou smears. J. Reprod. Medicine 34 (1989) 815-817.